Compound Evaluation in Scn2aQ54 Mice

Project: Research project

Description

To evaluate in vivo anti-seizure activity of three test compounds in the Scn2aQ54 mouse model of epilepsy caused by a mutation of Scn2a that results in elevated persistent sodium current (Kearney et al, 2001).
StatusActive
Effective start/end date12/9/188/31/19

Funding

  • Praxis Precision Medicines, Inc. (Prot #IS00004487)

Fingerprint

Epilepsy
Seizures
Sodium
Mutation